Historical record - last NADAC effective date: 6/23/2021
Product Information
NASAL DECONGESTANT 30 MG TAB is a generic product labeled by Topco Associates LLC, priced at $0.0539 per EA under NDC 36800043262. Its NADAC has been published 397 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
Topco Associates LLCNDC
36800043262
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/23/2021
Active Ingredients
PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
1/15/1988
Pharmacological Classes
Price Statistics
The NADAC for NASAL DECONGESTANT 30 MG TAB has been published 397 times since Nov 28, 2013, and over the history we have for it it has risen 31.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0539 per EA |
|---|---|
| All-time high | $0.0581 (Nov 11, 2020) |
| All-time low | $0.0409 (Nov 28, 2013) |
| Median price | $0.0487 |
| Average price | $0.0490 |
| Largest weekly change | +18.3% (May 19, 2021) |
| Weeks tracked | 397 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+31.9%
Last surveyed Jun 30, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Topco Associates LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pseudoephedrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NASAL DECONGESTANT 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for NASAL DECONGESTANT 30 MG TAB, manufactured by Topco Associates LLC, is $0.0539 per EA (NDC 36800043262), effective Jun 30, 2021.
How has the price of NASAL DECONGESTANT 30 MG TAB changed over time?
Over the history we have for it, the NADAC for NASAL DECONGESTANT 30 MG TAB has risen 31.9%. It has been tracked across 397 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NASAL DECONGESTANT 30 MG TAB?
Since Nov 28, 2013, the NADAC for NASAL DECONGESTANT 30 MG TAB has ranged from a low of $0.0409 (Nov 28, 2013) to a high of $0.0581 (Nov 11, 2020), with a median of $0.0487 per EA.
Are there cheaper alternatives to NASAL DECONGESTANT 30 MG TAB?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NASAL DECONGESTANT 30 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures NASAL DECONGESTANT 30 MG TAB?
NASAL DECONGESTANT 30 MG TAB (NDC 36800043262) is labeled by Topco Associates LLC, and CMS classifies it as a generic product.